Logo image of ICG

INTCHAINS GROUP LTD-ADR (ICG) Stock Fundamental Analysis

NASDAQ:ICG - Nasdaq - US45828E1047 - ADR - Currency: USD

2.09  -0.11 (-5%)

After market: 2.09 0 (0%)

Fundamental Rating

5

Taking everything into account, ICG scores 5 out of 10 in our fundamental rating. ICG was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. ICG is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ICG is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year ICG has reported negative net income.
ICG had a negative operating cash flow in the past year.
Of the past 5 years ICG 4 years were profitable.
In multiple years ICG reported negative operating cash flow during the last 5 years.
ICG Yearly Net Income VS EBIT VS OCF VS FCFICG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

The Return On Assets of ICG (4.69%) is better than 62.73% of its industry peers.
Looking at the Return On Equity, with a value of 5.05%, ICG is in line with its industry, outperforming 56.36% of the companies in the same industry.
ICG has a Return On Invested Capital (1.93%) which is in line with its industry peers.
Industry RankSector Rank
ROA 4.69%
ROE 5.05%
ROIC 1.93%
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ICG Yearly ROA, ROE, ROICICG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

ICG has a better Profit Margin (18.21%) than 77.27% of its industry peers.
In the last couple of years the Profit Margin of ICG has declined.
The Operating Margin of ICG (8.81%) is comparable to the rest of the industry.
ICG's Operating Margin has declined in the last couple of years.
The Gross Margin of ICG (53.38%) is better than 70.91% of its industry peers.
In the last couple of years the Gross Margin of ICG has grown nicely.
Industry RankSector Rank
OM 8.81%
PM (TTM) 18.21%
GM 53.38%
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
ICG Yearly Profit, Operating, Gross MarginsICG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICG is destroying value.
The number of shares outstanding for ICG remains at a similar level compared to 1 year ago.
There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ICG Yearly Shares OutstandingICG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
ICG Yearly Total Debt VS Total AssetsICG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

ICG has an Altman-Z score of 9.25. This indicates that ICG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.25, ICG is in the better half of the industry, outperforming 79.09% of the companies in the same industry.
There is no outstanding debt for ICG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 9.25
ROIC/WACC0.2
WACC9.7%
ICG Yearly LT Debt VS Equity VS FCFICG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 9.49 indicates that ICG has no problem at all paying its short term obligations.
ICG's Current ratio of 9.49 is amongst the best of the industry. ICG outperforms 95.45% of its industry peers.
A Quick Ratio of 8.18 indicates that ICG has no problem at all paying its short term obligations.
The Quick ratio of ICG (8.18) is better than 95.45% of its industry peers.
Industry RankSector Rank
Current Ratio 9.49
Quick Ratio 8.18
ICG Yearly Current Assets VS Current LiabilitesICG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

8

3. Growth

3.1 Past

ICG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 295.45%, which is quite impressive.
Measured over the past years, ICG shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -51.46% on average per year.
Looking at the last year, ICG shows a very strong growth in Revenue. The Revenue has grown by 242.96%.
The Revenue has been growing by 51.10% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)295.45%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%-1052.91%
Revenue 1Y (TTM)242.96%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%3810.5%

3.2 Future

Based on estimates for the next years, ICG will show a small growth in Earnings Per Share. The EPS will grow by 0.50% on average per year.
Based on estimates for the next years, ICG will show a very strong growth in Revenue. The Revenue will grow by 250.02% on average per year.
EPS Next Y117.54%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year395.95%
Revenue Next 2Y250.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ICG Yearly Revenue VS EstimatesICG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
ICG Yearly EPS VS EstimatesICG Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15 0.2 0.25

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ICG. In the last year negative earnings were reported.
ICG is valuated quite expensively with a Price/Forward Earnings ratio of 114.52.
Based on the Price/Forward Earnings ratio, ICG is valued a bit more expensive than the industry average as 67.27% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, ICG is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 114.52
ICG Price Earnings VS Forward Price EarningsICG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

ICG's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31
ICG Per share dataICG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ICG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.5%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ICG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

INTCHAINS GROUP LTD-ADR

NASDAQ:ICG (5/30/2025, 8:03:33 PM)

After market: 2.09 0 (0%)

2.09

-0.11 (-5%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-22 2025-05-22/amc
Earnings (Next)N/A N/A
Inst Owners0.23%
Inst Owner Change366.61%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap126.18M
Analysts80
Price Target9.69 (363.64%)
Short Float %0.08%
Short Ratio0.4
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-40.59%
Min EPS beat(2)-60.4%
Max EPS beat(2)-20.79%
EPS beat(4)1
Avg EPS beat(4)-7.92%
Min EPS beat(4)-147.52%
Max EPS beat(4)197.03%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-38.44%
Min Revenue beat(2)-40.57%
Max Revenue beat(2)-36.31%
Revenue beat(4)1
Avg Revenue beat(4)-9.78%
Min Revenue beat(4)-40.57%
Max Revenue beat(4)38.77%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-13.64%
EPS NQ rev (1m)0%
EPS NQ rev (3m)54.55%
EPS NY rev (1m)-42.86%
EPS NY rev (3m)-42.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)348.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)183.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 114.52
P/S 3.23
P/FCF N/A
P/OCF N/A
P/B 0.9
P/tB 0.9
EV/EBITDA 31
EPS(TTM)-0.06
EYN/A
EPS(NY)0.02
Fwd EY0.87%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS0.65
BVpS2.33
TBVpS2.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.69%
ROE 5.05%
ROCE 2.44%
ROIC 1.93%
ROICexc 1.93%
ROICexgc 1.94%
OM 8.81%
PM (TTM) 18.21%
GM 53.38%
FCFM N/A
ROA(3y)13.06%
ROA(5y)26.3%
ROE(3y)13.41%
ROE(5y)28.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-83.94%
ROICexcg growth 5YN/A
ROICexc growth 3Y-83.96%
ROICexc growth 5YN/A
OM growth 3Y-50.5%
OM growth 5YN/A
PM growth 3Y-36.68%
PM growth 5YN/A
GM growth 3Y-13.04%
GM growth 5Y25.49%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 221.73%
Cap/Sales 3.56%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.49
Quick Ratio 8.18
Altman-Z 9.25
F-Score5
WACC9.7%
ROIC/WACC0.2
Cap/Depr(3y)583.15%
Cap/Depr(5y)424.89%
Cap/Sales(3y)21.73%
Cap/Sales(5y)13.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)295.45%
EPS 3Y-51.46%
EPS 5YN/A
EPS Q2Q%-1052.91%
EPS Next Y117.54%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)242.96%
Revenue growth 3Y-23.58%
Revenue growth 5Y51.1%
Sales Q2Q%3810.5%
Revenue Next Year395.95%
Revenue Next 2Y250.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y138.13%
EBIT growth 3Y-62.17%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-170.52%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2829.94%
OCF growth 3YN/A
OCF growth 5YN/A